This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6 Aug 2013

Scottish Medicines Consortium accepts ADHD drug for children

The SMC has accepted a new ADHD treatment for children


The Scottish Medicines Consortium (SMC) has accepted lisdexamfetamine dimesylate for use in children with attention deficit/hyperactivity disorder (ADHD). 

Related News